Literature DB >> 9428001

Role of vascular nitric oxide in physiological and pathological conditions.

J Marín1, M A Rodríguez-Martínez.   

Abstract

This review describes the ability of certain diseases, such as essential hypertension, atherosclerosis, angina, and vasospasm, to reduce vascular nitric oxide (NO) formation or to increase its metabolism. In contrast, others, such as hypotension, sepsis, stroke, myocardial depression, and inflammatory responses, increase NO synthesis. The mechanism implicated in the changes in the formation and metabolism of NO are described. To prevent or treat these pathological processes, in which a deficiency in vascular NO formation plays a causative role, NO may be provided through methods such as direct NO administration or indirect NO supply through either NO donors or L-arginine, which facilitates NO formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428001     DOI: 10.1016/s0163-7258(97)00051-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  24 in total

1.  The hypotensive effect of the ruthenium complex [Ru(terpy)(bdq)NO]³⁺ is higher in male than in female spontaneously hypertensive rats (SHR).

Authors:  Simone R Potje; Mariana C Hildebrand; Felipe C Munhoz; Jéssica A Troiano; Ariana A F Pereira; Ana Claúdia M S Nakamune; Roberto S da Silva; Lusiane M Bendhack; Cristina Antoniali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-29       Impact factor: 3.000

2.  Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries.

Authors:  A M Briones; M J Alonso; J Marín; G Balfagón; M Salaices
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Red blood cell clearance in inflammation.

Authors:  Marleen Straat; Robin van Bruggen; Dirk de Korte; Nicole P Juffermans
Journal:  Transfus Med Hemother       Date:  2012-09-06       Impact factor: 3.747

4.  Characterization of an S-nitroso-N-acetylpenicillamine-based nitric oxide releasing polymer from a translational perspective.

Authors:  Marcus J Goudie; Elizabeth J Brisbois; Jitendra Pant; Alex Thompson; Joseph A Potkay; Hitesh Handa
Journal:  Int J Polym Mater       Date:  2016-06-15       Impact factor: 2.604

5.  Ischemic stroke due to carbon monoxide intoxication: Two case reports.

Authors:  Atif Bayramoglu; Abdullah Osman Kocak; Esra Kadioglu
Journal:  World J Emerg Med       Date:  2018

6.  Role of iNOS in the vasodilator responses induced by L-arginine in the middle cerebral artery from normotensive and hypertensive rats.

Authors:  A M Briones; M J Alonso; J Marín; M Salaices
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid.

Authors:  Renata Minuzzo Hartmann; Maria Isabel Morgan Martins; Juliana Tieppo; Henrique Sarubbi Fillmann; Norma Possa Marroni
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

8.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

9.  Measurement of plasma nitrite by chemiluminescence.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Methods Mol Biol       Date:  2010

10.  Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.

Authors:  Suresh Varma Penumathsa; Srikanth Koneru; Lijun Zhan; Saji John; Venogopal P Menon; Kailash Prasad; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2007-10-04       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.